Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer

NCT00122265 · clinicaltrials.gov ↗
TERMINATED
Status
83
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

AHS Cancer Control Alberta